Ajax Therapeutics
MA - CambridgeBiotechnology
Focus: Ajax Therapeutics is a computational chemistry and structural biology-focused biotechnology company headquartered in Cambridge, MA, founded in 2000 with public market status.
Profile data last refreshed 9h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Total Funding
$40M
Open Jobs
210+223 this month
Hot — 238 jobs added in 30d
Net +223 (238 new, 15 removed). Aggressive expansion phase.
Should You Work at Ajax Therapeutics?
AI assessmentA scientifically-grounded platform company with meaningful expertise, but current data suggests limited near-term clinical momentum or hiring—suitable primarily for research-focused roles in a stable but potentially stagnant environment.
Why Work Here
- Established 24-year track record in computational chemistry and structural biology with public company stability
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AJ1-11095
Primary MyelofibrosisClinical Trials (1)
NCT06343805A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Phase 1Help build intelligence for Ajax Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.